| Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers LJ Trevena, BJ Zikmund-Fisher, A Edwards, W Gaissmaier, M Galesic, ... BMC medical informatics and decision making 13 (2), 1-15, 2013 | 446 | 2013 |
| Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters G Elwyn, PJ Barr, SW Grande, R Thompson, T Walsh, EM Ozanne Patient education and counseling 93 (1), 102-107, 2013 | 248 | 2013 |
| The psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process PJ Barr, R Thompson, T Walsh, SW Grande, EM Ozanne, G Elwyn Journal of medical Internet research 16 (1), e3085, 2014 | 206 | 2014 |
| An approach to measuring the quality of breast cancer decisions K Sepucha, E Ozanne, K Silvia, A Partridge, AG Mulley Jr Patient education and counseling 65 (2), 261-269, 2007 | 160 | 2007 |
| Hypertension is an independent predictor of survival disparity between African‐American and white breast cancer patients D Braithwaite, CM Tammemagi, DH Moore, EM Ozanne, RA Hiatt, ... International Journal of Cancer 124 (5), 1213-1219, 2009 | 135 | 2009 |
| Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers A comparative effectiveness analysis KP Lowry, JM Lee, CY Kong, PM McMahon, ME Gilmore, JE Cott Chubiz, ... Cancer 118 (8), 2021-2030, 2012 | 116 | 2012 |
| Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines C O'Donoghue, M Eklund, EM Ozanne, LJ Esserman Annals of internal medicine 160 (3), 145-153, 2014 | 113 | 2014 |
| Characterizing the impact of 25 years of DCIS treatment EM Ozanne, Y Shieh, J Barnes, C Bouzan, ES Hwang, LJ Esserman Breast cancer research and treatment 129 (1), 165-173, 2011 | 107 | 2011 |
| Biologic markers determine both the risk and the timing of recurrence in breast cancer LJ Esserman, DH Moore, PJ Tsing, PW Chu, C Yau, E Ozanne, RE Chung, ... Breast cancer research and treatment 129 (2), 607-616, 2011 | 104 | 2011 |
| Balancing the presentation of information and options in patient decision aids: an updated review P Abhyankar, RJ Volk, J Blumenthal-Barby, P Bravo, A Buchholz, ... BMC medical informatics and decision making 13 (2), 1-10, 2013 | 101 | 2013 |
| Undetermined impact of patient decision support interventions on healthcare costs and savings: systematic review T Walsh, PJ Barr, R Thompson, E Ozanne, C O’Neill, G Elwyn Bmj 348, 2014 | 85 | 2014 |
| How to define and measure concordance between patients’ preferences and medical treatments: a systematic review of approaches and recommendations for standardization K Sepucha, EM Ozanne Patient education and counseling 78 (1), 12-23, 2010 | 82 | 2010 |
| Development of a personalized decision aid for breast cancer risk reduction and management EM Ozanne, R Howe, Z Omer, LJ Esserman BMC medical informatics and decision making 14 (1), 1-8, 2014 | 76 | 2014 |
| Cost-effectiveness of Breast MR Imaging and Screen-Film Mammography for Screening BRCA1 Gene Mutation Carriers JM Lee, PM McMahon, CY Kong, DB Kopans, PD Ryan, EM Ozanne, ... Radiology 254 (3), 793-800, 2010 | 75 | 2010 |
| Implementing breast cancer decision aids in community sites: barriers and resources KA Silvia, EM Ozanne, KR Sepucha Health Expectations 11 (1), 46-53, 2008 | 74 | 2008 |
| Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer MD Alvarado, AJ Mohan, LJ Esserman, CC Park, BL Harrison, RJ Howe, ... Annals of surgical oncology 20 (9), 2873-2880, 2013 | 70 | 2013 |
| Impact of ductal carcinoma in situ terminology on patient treatment preferences ZB Omer, ES Hwang, LJ Esserman, R Howe, EM Ozanne JAMA internal medicine 173 (19), 1830-1831, 2013 | 69 | 2013 |
| Which risk model to use? Clinical implications of the ACS MRI screening guidelines EM Ozanne, B Drohan, P Bosinoff, A Semine, M Jellinek, C Cronin, ... Cancer Epidemiology and Prevention Biomarkers 22 (1), 146-149, 2013 | 67 | 2013 |
| Using Collabo RATE, a brief patient‐reported measure of shared decision making: Results from three clinical settings in the United States RC Forcino, PJ Barr, AJ O'Malley, R Arend, MG Castaldo, EM Ozanne, ... Health expectations 21 (1), 82-89, 2018 | 60 | 2018 |
| Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome EM Ozanne, A Loberg, S Hughes, C Lawrence, B Drohan, A Semine, ... The breast journal 15 (2), 155-162, 2009 | 60 | 2009 |
Brian J. Zikmund-FisherUniversity of MichiganVerified email at umich.edu
